Buy or sell Seven Bridges stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Seven Bridges Stock

Seven Bridges is the leading biomedical data science company.

About Seven Bridges Stock

Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.

Funding History

September 2014$3.0M
February 2016$45.0M
April 2018$50.0M



Igor Bogicevic

Director of Program Management

Jack DiGiovanna

Senior Data Scientist

Nan Xiao

Chief Product Officer

Milan Mitrovic

Chief Scientific Officer

Brandi Davis-Dusenbery


Deniz Kural

Chief Technology Officer

Mladen Srdic

Chief Financial Officer

Robert Shay

Chief Executive Officer

William Moss

Chief Revenue Officer

Bruce Press


In Honor of Seven Bridges

New York Times - Mar, 21 2019

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Seven Bridges or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: